|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||17.05 - 17.32|
|52 Week Range||15.22 - 51.15|
|PE Ratio (TTM)||-2.81|
|Dividend & Yield||1.10 (6.43%)|
|1y Target Est||N/A|
Everyone knows high prescription drug prices are a problem, but except for pharma stockholders, few people may realize that price cuts are rippling through the generic side of the industry.
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Teva Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Sanofi Sponsored ADR, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Takeda Pharmaceutical Co. Ltd. Sponsored ADR and ... Read more (Read more...)
Teva Pharmaceutical Industries’ business has undergone significant turmoil over the past two years, as its stock price clearly indicates. Teva (TEVA) was originally founded in 1901 as a wholesale drug distributor in modern-day Israel. By 2015, Teva was the world’s largest generic pharmaceutical manufacturer.